| 000 | 01173 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516003207.0 | ||
| 264 | 0 | _c20110228 | |
| 008 | 201102s 0 0 eng d | ||
| 022 | _a1098-9064 | ||
| 024 | 7 |
_a10.1055/s-0030-1262888 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmlen, Woodruff | |
| 245 | 0 | 0 |
_aTherapeutic complement inhibition: new developments. _h[electronic resource] |
| 260 |
_bSeminars in thrombosis and hemostasis _cSep 2010 |
||
| 300 |
_a660-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngioedemas, Hereditary _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 |
_aComplement C1 Inhibitor Protein _xtherapeutic use |
| 650 | 0 | 4 |
_aComplement Pathway, Alternative _xdrug effects |
| 650 | 0 | 4 |
_aComplement System Proteins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aLi, Wenhan | |
| 700 | 1 | _aKirschfink, Michael | |
| 773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 36 _gno. 6 _gp. 660-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0030-1262888 _zAvailable from publisher's website |
| 999 |
_c20195467 _d20195467 |
||